Cargando…

TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)

BACKGROUND: Leishmania (Viannia) parasites present particular challenges, as human and murine immune responses to infection are distinct from other Leishmania species, indicating a unique interaction with the host. Further, vaccination studies utilizing small animal models indicate that modalities a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayakumar, Asha, Castilho, Tiago M., Park, Esther, Goldsmith-Pestana, Karen, Blackwell, Jenefer M., McMahon-Pratt, Diane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114751/ https://www.ncbi.nlm.nih.gov/pubmed/21695103 http://dx.doi.org/10.1371/journal.pntd.0001204

Ejemplares similares

CD4 T cell activation by B cells in human Leishmania (Viannia) infection
por: Rodriguez-Pinto, Daniel, et al.
Publicado: (2014)

Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis
por: Valdivia, Hugo O., et al.
Publicado: (2015)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
por: Robinson, HL, et al.
Publicado: (2009)

VianniaTopes: a database of predicted immunogenic peptides for Leishmania (Viannia) species
por: Llanes, Alejandro, et al.
Publicado: (2018)

Leishmania (Viannia) guyanensis Infection, Austria
por: Poeppl, Wolfgang, et al.
Publicado: (2012)

Evaluation of a Multilocus Sequence Typing (MLST) scheme for Leishmania (Viannia) braziliensis and Leishmania (Viannia) panamensis in Colombia
por: Herrera, Giovanny, et al.
Publicado: (2017)

Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
por: Ba, Lei, et al.
Publicado: (2007)

Leishmania (Viannia) naiffi: rare enough to be neglected?
por: Fagundes-Silva, Giselle Aparecida, et al.
Publicado: (2015)

Leishmania (Viannia) naiffi Lainson & Shaw 1989
por: Cantanhêde, Lilian Motta, et al.
Publicado: (2023)

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
por: Podola, L, et al.
Publicado: (2012)

Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults
por: Joachim, Agricola, et al.
Publicado: (2015)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

Human Macrophage Response to L. (Viannia) panamensis: Microarray Evidence for an Early Inflammatory Response
por: Ramírez, Carolina, et al.
Publicado: (2012)

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
por: Joachim, A, et al.
Publicado: (2012)

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
por: Munseri, P, et al.
Publicado: (2012)

Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama
por: Gonzalez, Kadir, et al.
Publicado: (2023)

A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
por: Carson, Connor, et al.
Publicado: (2009)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice
por: Chapman, Ros, et al.
Publicado: (2017)

Cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis in 2 travelers
por: Achtman, Jordan C., et al.
Publicado: (2016)

The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus.
por: Llanes, Alejandro, et al.
Publicado: (2015)

Mitochondrial genomics of human pathogenic parasite Leishmania (Viannia) panamensis
por: Urrea, Daniel Alfonso, et al.
Publicado: (2019)

Genomic Diversification, Structural Plasticity, and Hybridization in Leishmania (Viannia) braziliensis
por: Patino, Luz H., et al.
Publicado: (2020)

Toxicity and Anti-promastigote Activity of Benzoxazinoid Analogs Against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum
por: de Sousa, Gilberto, et al.
Publicado: (2020)

Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens
por: Ratto-Kim, Silvia, et al.
Publicado: (2012)

Human genetics of leishmania infections
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis
por: Giudice, Angela, et al.
Publicado: (2007)

Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection
por: Ovalle-Bracho, Clemencia, et al.
Publicado: (2015)

Coinfection of Leishmania (Viannia) braziliensis and Streptococcus pneumoniae in Multiple Cutaneous Lesions
por: Cortes, Paulo R., et al.
Publicado: (2016)

Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in Panama
por: González, Kadir, et al.
Publicado: (2018)

Leishmania (Viannia) braziliensis Inositol Phosphorylceramide: Distinctive Sphingoid Base Composition
por: De Castro Levatti, Erica V., et al.
Publicado: (2017)

Structural insights into leishmanolysins encoded on chromosome 10 of Leishmania (Viannia) braziliensis
por: Sutter, Amanda, et al.
Publicado: (2017)

First Report of Canine Infection by Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Santos, Francisco J. A., et al.
Publicado: (2020)

Intraspecific Genomic Divergence and Minor Structural Variations in Leishmania (Viannia) panamensis
por: Patino, Luz H., et al.
Publicado: (2020)

Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication
por: Pereira, Luiza O. R., et al.
Publicado: (2021)

Chemotaxis in Leishmania (Viannia) braziliensis: Evaluation by the two-chamber capillary assay
por: López, Emilia Díaz, et al.
Publicado: (2021)

Genetic diversity and population structure of Leishmania (Viannia) braziliensis in the Peruvian jungle
por: De los Santos, Maxy B., et al.
Publicado: (2022)

Leishmania (Viannia) guyanensis Causing Localized Cutaneous Leishmaniasis in a Traveler
por: Motie, Ian K, et al.
Publicado: (2022)

Therapeutic effect of oral quercetin in hamsters infected with Leishmania Viannia braziliensis
por: dos Santos, Rosiane Freire, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lp230gaddvl3f87aa542rhbn4g